Solutions Overview

Today’s cancer treatments are varied, complicated and costly. Oncology Analytics provides the critical missing link between health plans and providers: access to current, evidence-based, disease-specific analytics on all cancer types and treatment options.

Solutions that Put Patients First

It has been estimated that oncologists would need 29 hours a day to keep up with the research and findings of new cancer treatments that enter the market each day. Oncology Analytics relieves this burden through a combination of technology-enabled services, supported by our dedicated clinical team of board-certified oncology physicians and pharmacists.

OneUM™

A cross-benefit utilization management platform that encompasses both medical benefit and pharmacy benefit oncology drugs. With OneUM, treating oncology providers can use the latest in secure, cloud-based technology to submit a single e-Prior Authorization request for all oncology drug requests, since the platform includes treatment regimens that span both benefit types. This technology-enabled service speeds the complete review process and eliminates manual faxing and phone calls.
Read More

Oncology Insights Pro™

An analytics software solution that enables health plans and other risk-bearing entities to use data and analytics to improve oncology programs, as the costs and organizational importance of cancer care continue to increase. Oncology Insights Pro is unique compared to other healthcare analytics solutions by focusing on three key elements: real-world data, comparative benchmarking, and advisory services.
Read More

Pharmacy Consulting

A highly focused group of experienced and board-certified oncology pharmacy professionals, who partner with health plans to keep them up to date on the rapidly changing cancer therapy landscape to improve member care and ensure proper financial impact for the health plan.
Read More

OneUM™ for Pharmacy and Medical Benefit Drugs

OneUM™ by Oncology Analytics is a cross-benefit utilization management platform that encompasses both medical benefit and pharmacy benefit oncology drugs. With OneUM, providers can use a single e-Prior Authorization portal for all oncology drug requests, since the platform includes treatment regimens that span both benefit types. This improves quality of care, reduces provider abrasion, and gives health plans visibility into the total cost of oncology treatment.

OneUM™ is the only purpose-built for oncology solution available today that supports both oral and infused cancer therapies. We employ state of the art technology paired with evidence-based, real-world analytics to evaluate and approve treatments for cancer care—often in seconds.

Used by oncologists to support 5 million health plan members in the US and Puerto Rico, OneUM covers the full spectrum of therapeutics, across all cancer types and stages, including chemotherapy, immunotherapy, radiation therapy, genetic and molecular testing, and supportive care agents. Our extensive anti-cancer protocol library is continuously updated with the latest evidence-based information, which provides the most current options for value-based treatment paths for every patient case.

Oncology Analytics employs teams of board-certified medical oncologists, hematologists, and radiation oncologists, ensuring your providers will only speak to a true peer when discussing a member’s care. Our clinical oncology team has deep expertise in medical and pharmacy benefits as it relates to cancer drugs. They focus daily on identifying and evaluating new trends and researching appropriate therapy combinations, including biosimilars where applicable.

THINGS HAVE CHANGED
Since 2018 alone, the FDA approved 121 new cancer indications, including 49 novel cancer drug entities. The FDA has even launched a Real-Time Oncology Review (RTOR) program, which allows the FDA to review early drug data in advance of a formal application. Under this program, one oncology drug gained FDA approval within two weeks of the application filing.

Checking the box that a cancer therapy is supported by the National Comprehensive Cancer Network (NCCN) alone for coverage determinations is no longer enough. With so many NCCN supported options, health plans need to ensure their providers choose the most cost-effective option, tailored to provide the best outcome for the patient’s specific cancer. Oncology Analytics takes a more comprehensive approach by reviewing not only NCCN, but also FDA approvals, peer-reviewed journals using the Centers for Medicare & Medicaid Services (CMS) coverage rules, and the guidance of our internal oncologists who have decades of experience caring for patients.

At Oncology Analytics, each oncology review is evaluated using a patient-first approach, which balances the specific clinical need of each patient against comorbidities, toxicities, and cost. This approach facilitates our ability to provide treatment recommendations that reflect the most current evidence-based findings, even when there is a delay between when research is presented and its inclusion in NCCN.

Oncology Analytics’ OneUM platform has achieved a provider satisfaction score of over 95% by the 4,000 treating oncologists and their teams who use the platform daily. The submission process for prior authorization requests is completely automated and eliminates the need for faxes and burdensome administrative processes. Network providers can access the platform standalone or by integration into a health plan’s existing portal via single sign-on (SSO).

To learn more about our patient-first approach, please watch the following video.

“Oncology Analytics’ real-world data approach to utilization management is truly unique in the marketplace. We believe that it will provide significant value and efficiency to Gateway in managing both our medical and pharmacy benefits.”

Eric Yarnell, Vice President of Pharmacy, Gateway Health

Oncology Insights Pro™

Health plans are tasked with achieving optimal patient outcomes, with a focus on quality and cost. However, aggregating oncology data from multiple sources is a difficult task. Gaining immediate, actionable insights from the data is even more challenging.

Oncology Insights Pro™ is an analytics software solution that enables health plans and other risk-bearing entities to use data and analytics to improve oncology programs, as the organizational importance and costs of cancer care continue to increase.

Oncology Insights Pro is unique compared to other healthcare analytics solutions by focusing on three key elements:

REAL-WORLD DATA
Oncology Insights Pro organizes, normalizes and transforms payer claims data, eligibility data, and prior authorization data to create analytics dashboards with drill down capabilities. Our data science teams utilize advanced data modeling, machine learning, and predictive analytic algorithms to better understand outcomes to ensure that your members receive the right treatment at the right time and the right cost.

COMPARATIVE BENCHMARKING
Oncology Insights Pro creates HIPAA compliant de-identified data sets to enable health plans to compare their performance against other similar organizations in areas like oncology drug spend, drug trend, and provider network prescribing patterns. This proprietary benchmark data is only available to Oncology Analytics clients.

ADVISORY SERVICES
Health plans get access to a multi-disciplinary advisory team consisting of board-certified oncology pharmacists and clinical analysts who help interpret the data, surface immediate actionable insights and provide recommendations to close gaps.

Multiple product modules allow specific constituencies within your organization to take action to lower oncology spend, improve care quality, and make better strategic decisions.

To learn more about Oncology Insights Pro™, please watch the following video.

“This partnership brings focused oncology expertise to our prior authorization process. By offering this service, oncologists can consult with their peers and nationally recognized experts to confirm that they are providing the best care and value for their patients.”

Scott Schnuckle, HealthPartners Senior Vice President, Pharmacy and Business Development, HealthPartners

Oncology Pharmacy Consulting Services

New cancer treatments are entering the market at an unrelenting, accelerated pace. Since 2018 alone, the FDA approved over 136 new cancer indications, including 53 novel cancer drug entities. The FDA has even launched a Real-Time Oncology Review (RTOR) program, which allows the FDA to review early drug data in advance of a formal application. Under this program, one oncology drug gained FDA approval within two weeks of the application filing.

The explosive growth of treatment options in oncology means that the stakes for patients, providers, and health plans have never been higher. Health plans have small windows to carefully evaluate the appropriateness of new therapies and make needed course corrections.

WORK WITH AN EXPERT
Oncology Analytics’ team of board-certified oncology pharmacists can help you successfully navigate the world of anti-cancer drugs. These experienced professionals can assist by delivering a highly focused set of oncology pharmacy resources, which keep health plans up to date on the rapidly changing cancer therapy landscape. Through this increased awareness, health plans can improve cancer care for their members and develop more cost-effective approaches to high-quality care.

SERVICES WE OFFER
Oncology Analytics has both deep experience and a robust repository of effective tools and methods to guide health plans through the rapidly changing oncology drug landscape successfully. We have identified several high-value areas for oncology pharmacy optimization, and offer an 11 month consulting program which includes the following:

“It’s critical that Humana members receive effective and affordable cancer care. This expansion with Oncology Analytics is a great example of how Humana values our long-term relationships with partners who continue to innovate, drive quality, and add value for our members.”

Dr. Bryan Loy, Humana’s Corporate Medical Director of Oncology, Laboratory, and Personalized Medicine Strategies, Humana

Subscribe To Our Newsletter

Join our monthly mailing list to receive the latest news and updates from Oncology Analytics.

You have Successfully Subscribed!

Subscribe To Our Newsletter

Join our monthly mailing list to receive the latest news and updates from Oncology Analytics.

You have Successfully Subscribed!